The end of life costs for Medicare patients with advanced ovarian cancer.

•This provides a benchmark for end of life costs for women with advanced ovarian cancer.•The administration of chemotherapy at the end of life was common and significantly contributed to the cost of care.•The mean total cost of end of life care increased over time, and hospital admissions were a significant driver of costs.